Lung cancer|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Lung cancer

https://phgkb.cdc.gov/GAPPKB/phgHome.do



From NIH National Cancer Institute Web Sites

---

• Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options  
• Bringing Precision to Screening for Cancer  
• Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches  
• FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer  
• Targeted Photoimmunotherapy Approach for Cancer Moves Forward  
• Using Gene Expression to Diagnose Lung Cancer More Accurately  
• With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer